Protalix BioTherapeutics
PLX
#8687
Rank
ยฃ0.13 B
Marketcap
ยฃ1.61
Share price
1.42%
Change (1 day)
-19.07%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): ยฃ0.01352

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is ยฃ0.01508. In 2024 the company made an earnings per share (EPS) of ยฃ0.03016 a decrease over its 2023 EPS that were of ยฃ0.09049.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)ยฃ0.01352-55.17%
2024ยฃ0.03016-66.67%
2023ยฃ0.09049-138.71%
2022-ยฃ0.23-50%
2021-ยฃ0.47181.82%
2020-ยฃ0.17-82.11%
2019-ยฃ0.93-31.67%
2018-ยฃ1.36-72.31%
2017-ยฃ4.90124.14%
2016-ยฃ2.19-147.54%
2015ยฃ4.60-290.63%
2014-ยฃ2.416.67%
2013-ยฃ2.26130.77%
2012-ยฃ0.98-69.77%
2011-ยฃ3.2419.44%
2010-ยฃ2.71-12.2%
2009-ยฃ3.0936.67%
2008-ยฃ2.26-37.5%
2007-ยฃ3.6250%
2006-ยฃ2.413.23%
2005-ยฃ2.34138.46%
2004-ยฃ0.98-74%
2003-ยฃ3.77-0%
2002-ยฃ3.77-50%
2001-ยฃ7.54233.33%
2000-ยฃ2.26-84.21%
1999-ยฃ14.33-24%
1998-ยฃ18.85-600%
1997ยฃ3.77-16.67%
1996ยฃ4.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
ยฃ1.03 6,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ3.63 24,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-ยฃ0.08295-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.94 6,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel